Literature DB >> 12694964

Pregnancy as a risk factor for acute toxoplasmosis seroconversion.

Mariza Martins Avelino1, Dioclécio Campos, Josetti do Carmo Barbosa de Parada, Ana Maria de Castro.   

Abstract

OBJECTIVE: To test the hypothesis that pregnancy is a risk factor for toxoplasmosis seroconversion.
MATERIALS AND METHODS: A prospective observational study of women at child-bearing age vulnerable to Toxoplasma gondii. Serological reactions with indirect immunofluorescent antibody and immunoenzyme tests were used. The risk estimate used limits of reliability at 95%, and the results were validated by chi(2) and RR tests.
RESULTS: Acute infection among pregnant women was 8.6% (45/522), and pregnancy was confirmed to be a risk factor for seroconversion (P=0.001). Living in close contact with host animals and vehicles of oocyst transmission proved to be a statistical risk for pregnant women to seroconvert, which was aggravated in adolescents.
CONCLUSION: Gestation, potentiating susceptibility to this infection, points to the need of primary and secondary prevention for all pregnant women at risk.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12694964     DOI: 10.1016/s0301-2115(02)00353-6

Source DB:  PubMed          Journal:  Eur J Obstet Gynecol Reprod Biol        ISSN: 0301-2115            Impact factor:   2.435


  19 in total

1.  An unusual case of disseminated toxoplasmosis in a previously healthy pregnant patient: radiographic, CT, and MRI findings.

Authors:  Samir Paruthikunnan; Balasubramanyam Shankar; Rajagopal Kadavigere; Mukhyaprana Prabhu; Ramakrishna Narayanan; Harshwardhan Jain
Journal:  Jpn J Radiol       Date:  2014-08-24       Impact factor: 2.374

2.  Public health approach to emerging infections among pregnant women.

Authors:  Sonja A Rasmussen; Edward B Hayes
Journal:  Am J Public Health       Date:  2005-09-29       Impact factor: 9.308

3.  Cutting Edge: Fetal/Placental Type I IFN Can Affect Maternal Survival and Fetal Viral Load during Viral Infection.

Authors:  Karen Racicot; Paulomi Aldo; Ayman El-Guindy; Ja-Young Kwon; Roberto Romero; Gil Mor
Journal:  J Immunol       Date:  2017-03-06       Impact factor: 5.422

Review 4.  Serum alanine aminotransferase flares in chronic hepatitis B infection: the good and the bad.

Authors:  Marc G Ghany; Jordan J Feld; Kyong-Mi Chang; Henry L Y Chan; Anna S F Lok; Kumar Visvanathan; Harry L A Janssen
Journal:  Lancet Gastroenterol Hepatol       Date:  2020-02-10

5.  High seroprevalence of antibodies to Toxoplasma gondii in wild animals from Portugal.

Authors:  Ana Patrícia Lopes; Roberto Sargo; Manuela Rodrigues; Luís Cardoso
Journal:  Parasitol Res       Date:  2010-11-23       Impact factor: 2.289

6.  Parity and placental infection affect antibody responses against Plasmodium falciparum during pregnancy.

Authors:  Alfredo Mayor; Eduard Rovira-Vallbona; Sonia Machevo; Quique Bassat; Ruth Aguilar; Llorenç Quintó; Alfons Jiménez; Betuel Sigauque; Carlota Dobaño; Sanjeev Kumar; Bijender Singh; Puneet Gupta; Virander S Chauhan; Chetan E Chitnis; Pedro L Alonso; Clara Menéndez
Journal:  Infect Immun       Date:  2011-02-07       Impact factor: 3.441

7.  Split immunological tolerance to trophoblast.

Authors:  Amanda de Mestre; Leela Noronha; Bettina Wagner; Douglas F Antczak
Journal:  Int J Dev Biol       Date:  2010       Impact factor: 2.203

Review 8.  Emerging infections and pregnancy.

Authors:  Denise J Jamieson; Regan N Theiler; Sonja A Rasmussen
Journal:  Emerg Infect Dis       Date:  2006-11       Impact factor: 6.883

9.  Seroepidemiology of Toxoplasma gondii infection in women of child-bearing age in central Ethiopia.

Authors:  Endrias Zewdu Gebremedhin; Anteneh Hailu Abebe; Tesfaye Sisay Tessema; Kassu Desta Tullu; Girmay Medhin; Maria Vitale; Vincenzo Di Marco; Eric Cox; Pierre Dorny
Journal:  BMC Infect Dis       Date:  2013-02-26       Impact factor: 3.090

Review 10.  Pregnancy and susceptibility to infectious diseases.

Authors:  Elisabeth Sappenfield; Denise J Jamieson; Athena P Kourtis
Journal:  Infect Dis Obstet Gynecol       Date:  2013-07-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.